Literature DB >> 23498292

Diabetes prevention and the role of risk factor reduction in the Medicare population.

Elizabeth A Koller1, Joseph S Chin, Patrick H Conway.   

Abstract

Medicare is keenly aware of the secular changes in weight gain and of the nearly parallel increases in both the incidence and prevalence of type 2 diabetes throughout the U.S. population. The Medicare population, however, differs from the population at large because of its advanced age and frequency of comorbid conditions and/or disability. These factors affect life span as well as participation in and potential benefit from lifestyle modification and risk-factor reduction activities. Further, macrovascular disease is the greatest burden for older beneficiaries with diabetes, and its risks may antedate the appearance of hyperglycemia. Both diabetes prevention and treatment must be considered in this context. Medicare benefits focus on reduction of cardiovascular risk and mitigation of more temporally immediate complications of weight gain and glucose elevation. These preventive services and interventions are described. Published by Elsevier Inc.

Entities:  

Mesh:

Year:  2013        PMID: 23498292     DOI: 10.1016/j.amepre.2012.12.019

Source DB:  PubMed          Journal:  Am J Prev Med        ISSN: 0749-3797            Impact factor:   5.043


  2 in total

1.  Statins are associated with new onset type 2 diabetes mellitus (T2DM) in Medicare patients ≥65 years.

Authors:  Srikanth Tangelloju; Bert B Little; Robert J Esterhay; Guy Brock; Scott LaJoie
Journal:  Diabetes Metab Res Rev       Date:  2020-04-03       Impact factor: 8.128

2.  Occupational differences, cardiovascular risk factors and lifestyle habits in South Eastern rural Australia.

Authors:  Nathalie Davis-Lameloise; Benjamin Philpot; Edward D Janus; Vincent L Versace; Tiina Laatikainen; Erkki A Vartiainen; James A Dunbar
Journal:  BMC Public Health       Date:  2013-11-23       Impact factor: 3.295

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.